Process economics evaluation of cell-free synthesis for the commercial manufacture of antibody drug conjugates (2020)
Attributed to:
FUTURE TARGETED HEALTHCARE MANUFACTURING HUB
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.22541/au.158861421.10410013
Publication URI: http://dx.doi.org/10.22541/au.158861421.10410013
Type: Preprint